-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: developing countries
More Farmers Around the World Plant Biotech Crops
ISAAA (International Service for the Acquisition of Agri-Biotech Applications) released their annual report last week on the Global Status of Commercialized Biotech/GM Crops: 2012, showing a record 17.3 million farmers in 28 countries are growing biotech crops on 420 million acres. That marks a pretty stunning 100-fold increase since biotech crops were first commercialized in 1996. Even more impressive is the role developing countries are playing in the growth of biotech crops. Business-Standard.com reported on Read More >
What Will It Take for the U.S. to Maintain Leadership in the Biopharma Industry?
The biopharmaceutical industry is an important contributor to U.S. economic growth and sustainability, with more than 650,000 direct jobs (supporting a total of nearly 4 million jobs) and an economic output that totals more than $900 billion.[i] This significant economic impact is due to the high value-added nature of the sector, its extensive supply chain relationships, and high-wage jobs. As a result, gains and losses in the biopharmaceutical sector cascade across many important economic sectors Read More >
Biotech addresses food security, climate change: Potential economic growth engine
By Jose W. Fernandez, Assistant Secretary of State for Economic, Energy and Business Affairs By 2050, the global population will surpass 9 billion and require nearly a doubling of agricultural output to provide an adequate food supply. At the same time, the world’s agricultural system will be increasingly challenged by water scarcity and climate change, raising the risk of production shortfalls in a world where over 800 million people are already undernourished. A challenge like Read More >
If Biotech Builds…Will Financers Come?
Angie Drakulich from PharmaTech Talk writes: In many countries, it’s easy to get the health minister to understand the value of introducing a vaccine and related healthcare training and therapies to his or her population. It’s another thing to get the finance minister to buy into the effort. But healthcare education and training have made and continue to make great inroads into this area. Angie is part of our BIO Official Blog Program. Keep an Read More >
Podcast: Melinda Moree, CEO of BIO Ventures for Global Health
BIO Ventures for Global Health, together with BIO, is co-host of the upcoming Partnering for Global Health Forum at the BIO International Convention. Moree discusses the Forum and the importance of partnering to improving the health of people in developing countries. Download the podcast
